Skip to main content
. 2018 Mar 26;19(4):991. doi: 10.3390/ijms19040991

Figure 4.

Figure 4

Serum ceramides (Cer) and dihydro-ceramides (DHC) in post-orthopic liver transplantation (OLT) patients with a history of hepatocellular carcinoma (HCC) pre-OLT. C24:1Cer (A) and C24:1DHC (B) are significantly up-regulated in patients with HCC pre-OLT, compared to no prior HCC (** p < 0.01).